J9044 — Injection, bortezomib, not otherwise specified, 0.1 mg
J9044 is a HCPCS Level II code for injection, bortezomib, not otherwise specified, 0.1 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2022 and is not valid on new claims.
This code has been terminated
CMS terminated J9044 on December 31, 2022. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J9044
- Long descriptor
- Injection, bortezomib, not otherwise specified, 0.1 mg
- Short descriptor
- Inj, bortezomib, nos, 0.1 mg
- Added
- January 1, 2019
- Terminated
- December 31, 2022
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J9044
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J9044 is not quite right, the correct code is very often within a few positions of it.
- J9036Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg
- J9037Injection, belantamab mafodotin-blmf, 0.5 mgterminated
- J9038Injection, axatilimab-csfr, 0.1 mg
- J9039Injection, blinatumomab, 1 microgram
- J9040Injection, bleomycin sulfate, 15 units
- J9041Injection, bortezomib, 0.1 mg
- J9042Injection, brentuximab vedotin, 1 mg
- J9043Injection, cabazitaxel, 1 mg
- J9045Injection, carboplatin, 50 mg
- J9046Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg
- J9047Injection, carfilzomib, 1 mg
- J9048Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg
- J9049Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg
- J9050Injection, carmustine, 100 mg
- J9051Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg
- J9052Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mg
Questions about J9044
What is HCPCS code J9044?
J9044 is a HCPCS Level II code for injection, bortezomib, not otherwise specified, 0.1 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J9044?
The CMS HCPCS file marks J9044 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
Is J9044 still valid?
No. J9044 was terminated on December 31, 2022 and should not be used on new claims.